Dr. Mehan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3015 N Ballas Rd
Des Peres, MO 63131Phone+1 314-996-5169Fax+1 314-996-5674
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2010 - 2013- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2006 - 2009
Loyola University Chicago Stritch School of MedicineClass of 2006
Certifications & Licensure
MO State Medical License 2009 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013
Publications & Presentations
PubMed
- 32 citationsA phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced s...Douglas Adkins, Jessica Ley, Kathryn Trinkaus, Wade L. Thorstad, James S. Lewis
Cancer. 2013-02-15 - 43 citationsCisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell CarcinomaJessica Ley, Paul Mehan, Tanya M. Wildes, Wade L. Thorstad, Loren S. Michel
Oncology. 2013-01-01 - 194 citationsPhase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma...Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip, Sunil R. Hingorani, Jill Lacy
Journal of Clinical Oncology. 2019-02-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
